title: The CD39-adenosinergic axis in the pathogenesis of renal ischemia-reperfusion injury.
abstract: Hypoxic injury occurs when the blood supply to an organ is interrupted; subsequent reperfusion halts ongoing ischemic damage but paradoxically leads to further inflammation. Together this is termed ischemia-reperfusion injury (IRI). IRI is inherent to organ transplantation and impacts both the short- and long-term outcomes of the transplanted organ. Activation of the purinergic signalling pathway is intrinsic to the pathogenesis of, and endogenous response to IRI. Therapies targeting the purinergic pathway in IRI are an attractive avenue for the improvement of transplant outcomes and the basis of ongoing research. This review aims to examine the role of adenosine receptor signalling and the ecto-nucleotidases, CD39 and CD73, in IRI, with a particular focus on renal IRI.
authors.affiliation: St. Vincent's Hospital Melbourne, Immunology Research Centre, Melbourne, Australia. veena.roberts@svhm.org.au
authors.forename: Veena
authors.initials: V
authors.lastname: Roberts
authors.forename: Bo
authors.initials: B
authors.lastname: Lu
authors.forename: Siddharth
authors.initials: S
authors.lastname: Rajakumar
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Cowan
authors.forename: Karen M
authors.initials: KM
authors.lastname: Dwyer
mesh_terms: D000241:Adenosine / Q000378:metabolism*; D000818:Animals; D015703:Antigens, CD / Q000378:metabolism*; D001081:Apyrase / Q000378:metabolism*; D006801:Humans; D007668:Kidney / Q000378:metabolism* / Q000473:pathology; D016030:Kidney Transplantation; D015427:Reperfusion Injury / Q000378:metabolism* / Q000473:pathology; D015398:Signal Transduction / Q000502:physiology*
chemical_list: D015703:Antigens, CD; D001081:Apyrase; C067869:CD39 antigen; D000241:Adenosine